Windlas Biotech Makes Weak Market Debut; Lists At Discount Of 5%
Windlas Biotech shares made a weak debut on stock exchanges on Monday as the stock opened for trading at Rs 437 on the National Stock Exchange (NSE), marking a discount of 5 per cent from issue price of Rs 460. Windlas Biotech shares were in high demand in the three-day share sale via initial public offering (IPO) which ended on August 6. The IPO was subscribed 22 times wherein the portion reserved for Qualified Institutional Buyers was subscribed 24.4 times and portion for Retail Individual Investors was subscribed 24.27 times.
Windlas Biotech's Rs 401.5 crore IPO comprised a fresh issue of Rs 165 crore and an offer for sale worth Rs 236.5 crore. The leading pharmaceutical company sold shares in the price band of Rs 448 to Rs 460 per equity share.
Windlass Biotech sought to utilise proceeds from IPO to purchase the equipment required for the capacity expansion of its existing facility at Dehradun Plant IV. It also sought to finance the incremental working capital requirements of the company, repay its borrowings, and for general corporate purposes.
Windlas Biotech is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in the country. The company provides a range of CDMO services such as licensing, product discovery to product development, and commercial manufacturing of generic products including complex generics.
The company has a strong focus on the chronic therapeutic category and is a leading market player in the domestic pharmaceutical formulation CDMO segment.
As of 10:23 am, Windlas Biotech shares traded 7.5 per cent lower from issue price at Rs 425.70. The stock fell as much as 12 per cent to hit an intraday low of Rs 407.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
